You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Integrase inhibitor

Showing 26 - 50 of 7,501
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial in Liuzhou, Najing, Tianjin (B/F/TAF, TDF/3TC/EFV)

Recruiting
  • HIV-1-infection
  • Liuzhou, Guangxi, China
  • +2 more
Mar 31, 2022

HIV, Acute HIV Infection Trial in Chapel Hill, Durham (Dolutegravir 50 mg, Lamivudine 300 mg, Abacavir 600 mg)

Completed
Has Results
  • HIV
  • Acute HIV Infection
  • Dolutegravir 50 mg
  • +2 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 22, 2021

HIV Jail POC-AgAB Testings

Active, not recruiting
  • HIV/AIDS
  • POC
  • +2 more
  • Atlanta, Georgia
    Emory University
Jul 18, 2022

HIV Trial in Nijmegen (Triumeq, Triumeq crushed + breakfast, Triumeq crushed + drip feed)

Completed
  • HIV
  • Nijmegen, Netherlands
    CRCN, Radboud University Medical Center
Dec 4, 2020

HIV, AIDS Trial in Durban, Mbarara (HIV-1 RNA Resistance Testing)

Completed
Has Results
  • HIV
  • AIDS
  • HIV-1 RNA Resistance Testing
  • Durban, South Africa
  • +1 more
Mar 28, 2022

HIV Trial in Paris (Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine)

Not yet recruiting
  • HIV Infections
  • Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine
  • Paris, Ile De France, France
    Christine Katlama
Jul 26, 2022

HIV Trial in Worldwide (Raltegravir poloxamer film coated tablet, Raltegravir chewable tablet, Raltegravir oral granules for

Completed
Has Results
  • HIV Infections
  • Raltegravir poloxamer film coated tablet
  • +2 more
  • Alhambra, California
  • +41 more
Oct 29, 2021

Large Scale Transition toDolutegravir-based First-line ART in

Not yet recruiting
  • HIV Infections
    • Abidjan, Côte D'Ivoire
    • +2 more
    Mar 28, 2022

    Human Immunodeficiency Virus Trial in Oakland Park (bictegravir/emtricitabine/tenofovir alafenamide)

    Completed
    • Human Immunodeficiency Virus
    • bictegravir/emtricitabine/tenofovir alafenamide
    • Oakland Park, Florida
      Midland Research Group, Inc
    Feb 23, 2021

    Multi Drug Resistant Tuberculosis, HIV Trial in Durban (Adherence support intevention)

    Not yet recruiting
    • Multi Drug Resistant Tuberculosis
    • HIV Infections
    • Adherence support intevention
    • Durban, KwaZulu-Natal, South Africa
      King DinuZulu Hospital
    Nov 21, 2022

    PRJ2203: Dolutegravir Post Authorization Safety Study (PASS)

    Completed
    • Infection, Human Immunodeficiency Virus I
    • DTG based ARV regimen with ABC
    • +4 more
    • (no location specified)
    Feb 5, 2020

    Aging-related Inflammation in HIV-infected Patients Trial in Badalona (Raltegravir, PI-based regimen, Atorvastatin)

    Completed
    Has Results
    • Aging-related Inflammation in HIV-infected Patients
    • Badalona, Barcelona, Spain
      Germans Trias i Pujol Hospital
    Oct 7, 2020

    Human Immunodeficiency Virus Trial in Boston, New York (3BNC117, 10-1074, Analytical treatment interruption)

    Completed
    • Human Immunodeficiency Virus
    • Boston, Massachusetts
    • +1 more
    Feb 11, 2022

    Ageing on 'Pharmacokinetic and Clinical Observations in People

    Active, not recruiting
    • HIV Positive
    • Ageing
      • Dublin, Ireland
      • +7 more
      Jul 5, 2021

      HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)

      Recruiting
      • HIV I Infection
      • +2 more
      • Doravirine 100 Mg
      • Los Angeles, California
      • +1 more
      Nov 1, 2022

      HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

      Recruiting
      • HIV-1-infection
      • Kisumu, Kenya
      • +6 more
      Feb 1, 2023

      Pre-Exposure Prophylaxis (PrEP), Breast Feeding Trial in Boston, Gaborone (Cabotegravir Injection [Apretude])

      Not yet recruiting
      • Pre-Exposure Prophylaxis (PrEP)
      • Breast Feeding
      • Cabotegravir Injection [Apretude]
      • Boston, Massachusetts
      • +1 more
      Aug 3, 2023

      Body Composition, Bone Health and Hormonal Status in

      Terminated
      • HIV-1
      • Treatment-naïve
      • DXA scan
      • +3 more
      • Jette, Belgium
        UZ Brussel
      Oct 12, 2018

      HIV-1-infection Trial in Kisumu, Nairobi (Switch to B/F/TAF, Continue current regimen)

      Active, not recruiting
      • HIV-1-infection
      • Switch to B/F/TAF
      • Continue current regimen
      • Kisumu, Kenya
      • +1 more
      May 24, 2022

      Malaria Trial in Belfast (Midazolam, Repaglinide, Dextromethorphan)

      Completed
      • Malaria
      • Belfast, Northern Ireland, United Kingdom
        Novartis Investigative Site
      Nov 2, 2022

      Risk Reduction Trial in Cape Town (UTRA, UTRA feedback)

      Recruiting
      • Risk Reduction
      • UTRA
      • UTRA feedback
      • Cape Town, Western Cape, South Africa
        Desmond Tutu Health Foundation, University of Cape Town
      May 17, 2022

      HIV Trial in Rio De Janeiro (Cabotegravir Injection)

      Not yet recruiting
      • HIV Infections
      • Cabotegravir Injection
      • Rio De Janeiro, Brazil
        Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ
      Aug 23, 2022

      Virologic Failure and Drug Resistance at and After Switching to

      Active, not recruiting
      • Hiv
      • +2 more
        • Lilongwe, Malawi
        • +1 more
        Feb 14, 2022

        HIV-1-infection Trial in Butha-Buthe (Dolutegravir)

        Active, not recruiting
        • HIV-1-infection
        • Butha-Buthe, Lesotho
        • +1 more
        Oct 23, 2022

        HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)

        Recruiting
        • HIV Infections
        • Doravirine 100 Mg
        • +5 more
        • Birmingham, Alabama
        • +22 more
        Feb 22, 2022